Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice

scientific article

Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1002905114
P356DOI10.1186/1475-2875-13-487
P932PMC publication ID4295290
P698PubMed publication ID25495520
P5875ResearchGate publication ID269720734

P50authorFrances C RecuencoQ84391543
P2093author name stringTaisuke Horimoto
Ryo Takano
Kentaro Kato
Hitoshi Takemae
Tatsuki Sugi
Fumi Murakoshi
Noriyuki Horiuchi
Yoshiyasu Kobayashi
Akiko Ishiwa
Atsuko Inomata
Shiori Chiba
P2860cites workCerebral malaria: mysteries at the blood-brain barrierQ21032533
A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malariaQ27318676
Neuroimmunological blood brain barrier opening in experimental cerebral malariaQ27341951
Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytesQ35483364
Cytokine profile suggesting that murine cerebral malaria is an encephalitisQ35559322
Sequestration and microvascular congestion are associated with coma in human cerebral malariaQ35694762
A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction.Q36595999
Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9.Q37359865
Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory painQ37561363
Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injuryQ37703098
Gellan sulfate inhibits Plasmodium falciparum growth and invasion of red blood cells in vitro.Q37707381
The pathology of human cerebral malariaQ37948795
Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36.Q40398384
Breaking free of sample size dogma to perform innovative translational researchQ42117164
Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinomaQ43627527
Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.Q44138424
Suppression of allergic reaction by lambda-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunityQ44311506
Extremely small sample size in some toxicity studies: an example from the rabbit eye irritation testQ47211247
Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria.Q47842059
Pathology of fatal and resolving Plasmodium berghei cerebral malaria in miceQ47848359
Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent mannerQ47980772
Plasmodium berghei: effect of carrageenan on the course of infection of the A/J mouseQ47991753
Saccharide anions as inhibitors of the malaria parasiteQ48037140
Carrageenan-induced intestinal injury in the rat--a model for inflammatory bowel diseaseQ70235514
Anaphylaxis to carrageenan: a pseudo-latex allergyQ72239852
P921main subjectmalariaQ12156
cerebral malariaQ2822915
Plasmodium bergheiQ65021
P304page(s)487
P577publication date2014-12-11
P1433published inMalaria JournalQ15749954
P1476titleLambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice
P478volume13

Reverse relations

Q48005441Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Developmentcites workP2860

Search more.